Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Visualizing immunoreceptor forces and their effects in vivo.

bioRxiv : the preprint server for biology·2026
Same author

Smoking inequalities among culturally diverse populations in Australia: A secondary dataset analysis of the HILDA survey 2002-2019.

Tobacco induced diseases·2026
Same author

Activating antiviral defenses warms up cold tumours.

Nature nanotechnology·2026
Same author

The Impact of Front-of-Pack Labeling on Social Inequality in Sugar Consumption and Purchase: A Systematic Review.

Obesity reviews : an official journal of the International Association for the Study of Obesity·2026
Same author

DNA cross-over motifs-based, programmable supramolecular hydrogels for the mechanoregulatory effects of cellular behaviour and cytoskeleton reorganization.

npj biomedical innovations·2026
Same author

Efficacy of PicoSure Laser in Treating Lichen Planus Pigmentosus and Pigmentary Demarcation Lines in Patients With Skin of Color.

Journal of cosmetic dermatology·2026

Related Experiment Video

Updated: Apr 25, 2026

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
09:39

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

9.2K

Hydrogels and scaffolds for immunomodulation.

Ankur Singh1, Nicholas A Peppas

  • 1Sibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, NY, 14853, USA.

Advanced Materials (Deerfield Beach, Fla.)
|August 27, 2014
PubMed
Summary
This summary is machine-generated.

Biomaterial scaffolds are emerging as a promising approach for cancer vaccination and treating immune diseases. This research highlights hydrogel and scaffold-based immunomodulatory strategies for improved therapeutic translation.

Keywords:
biomaterialshydrogelsimmunologyimmunomodulationpolymersscaffolds

More Related Videos

Gelatin Methacryloyl Granular Hydrogel Scaffolds: High-throughput Microgel Fabrication, Lyophilization, Chemical Assembly, and 3D Bioprinting
10:36

Gelatin Methacryloyl Granular Hydrogel Scaffolds: High-throughput Microgel Fabrication, Lyophilization, Chemical Assembly, and 3D Bioprinting

Published on: December 9, 2022

7.4K
Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation
09:19

Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation

Published on: December 8, 2017

14.7K

Related Experiment Videos

Last Updated: Apr 25, 2026

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
09:39

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

9.2K
Gelatin Methacryloyl Granular Hydrogel Scaffolds: High-throughput Microgel Fabrication, Lyophilization, Chemical Assembly, and 3D Bioprinting
10:36

Gelatin Methacryloyl Granular Hydrogel Scaffolds: High-throughput Microgel Fabrication, Lyophilization, Chemical Assembly, and 3D Bioprinting

Published on: December 9, 2022

7.4K
Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation
09:19

Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation

Published on: December 8, 2017

14.7K

Area of Science:

  • Immunology
  • Biomaterials Science
  • Cancer Therapy
  • Vaccine Development

Background:

  • For over 20 years, immunologists and biomaterials scientists have explored immune responses to biomaterials for vaccination, implantation, and disease treatment.
  • Previous research often used model antigens like chicken egg ovalbumin in mice, raising questions about human relevance.
  • Despite limitations, model antigens provided insights into immune regulation and proof-of-concept for biomaterial-based vaccines.

Purpose of the Study:

  • To provide insight into emerging hydrogel and scaffold-based immunomodulatory approaches.
  • To highlight the efficacy of these approaches against immune-associated diseases.
  • To discuss the potential of scaffold vaccines in human models for cancer vaccination and other immune-related conditions.

Main Methods:

  • Review of existing literature on biomaterial-based immunomodulation, focusing on hydrogels and scaffolds.
  • Analysis of recent experimental scaffold vaccines utilizing patient-derived tumor lysates and immunomodulatory proteins in human models.
  • Comparison with traditional approaches using model antigens and micro/nano-particles.

Main Results:

  • Hydrogel and scaffold-based immunomodulatory approaches are demonstrating efficacy against immune-associated diseases.
  • Experimental scaffold vaccines co-delivering tumor lysates and immunomodulatory proteins show promise in human models for cancer vaccination.
  • These novel approaches offer a more rational and faster translation of therapeutic strategies.

Conclusions:

  • Emerging hydrogel and scaffold-based immunomodulatory strategies represent a significant advancement in treating immune-associated diseases.
  • Scaffold vaccines hold transformative potential for untreatable cancers and can accelerate translation to other diseases like chronic infections and autoimmune disorders.
  • This approach moves beyond traditional model antigens and micro/nano-particles, offering a more human-relevant platform for therapeutic development.